Claims
- 1. A method of treating a disorder of the serotonergic system in a human, which comprises administering to the human in need of the treatment an oral daily dosage of about 20 mg to about 60 mg of deramciclane.
- 2. A method according to claim 1, wherein the disorder is anxiety.
- 3. A method according to claim 2, wherein the anxiety is chronic.
- 4. A method according to claim 3, wherein the patient does not experience relapse of the disorder.
- 5. A method according to claim 2, wherein the disorder is generalized anxiety disorder.
- 6. A method according to claim 1, wherein the daily dosage of deramciclane is about 30 mg to about 60 mg.
- 7. A method according to claim 1, wherein the daily dosage of deramciclane is about 30 mg.
- 8. A method according to claim 1, wherein the daily dosage of deramciclane is about 20 mg to about 40 mg.
- 9. A method according to claim 1, which comprises administering the deramciclane in a once-a-day formulation.
- 10. A method of treating depression in a human, which comprises administering to the human in need of the treatment a therapeutically effective amount of deramciclane.
- 11. A method according to claim 10, wherein the deramciclane is administered orally.
- 12. A method according to claim 11, which comprises administering a daily dosage of about 20 mg to about 60 mg of deramciclane.
- 13. A method according to claim 11, which comprises administering about 30 mg to about 60 mg of deramciclane.
- 14. A method according to claim 11, which comprises administering about 30 mg of deramciclane.
- 15. A method according to claim 11, which comprises administering about 20 mg to about 40 mg of deramciclane.
- 16. A method according to claim 11, which comprises administering the deramciclane in a once-a-day formulation.
- 17. A method of treating a disorder of the serotonergic system in a human, which comprises administering to the human in need of the treatment a standard daily dosage of deramciclane to treat the disorder, and then abruptly terminating the treatment.
- 18. A method according to claim 17, wherein the standard daily dosage is given to the patient for at least three weeks.
- 19. A method according to claim 17, wherein the standard daily dosage is about 20 to about 60 mg.
- 20. A method according to claim 18, wherein the standard daily dosage is about 20 to about 60 mg.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority under 35 U.S.C. § 119(e) to U.S. provisional application No. 60/190,032, filed on Mar. 17, 2000, the contents of which are incorporated by reference herein.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60190032 |
Mar 2000 |
US |